| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cytoplasmic ribosomal proteins 0.5183785459382179 4.386842505376697 1.1500800253250176e-05 0.0070138177892811 0.0070384897549897 77 P15880,P62847,P05387,P62841,P83731,P08865,P62913,Q15418,P18621,P62081,Q07020,P63220,Q9Y3U8,P61313,P61513,P35268,P05388,P08708,P42766,P62244,P39019,P50914,P46777,P40429,P62910,P84098,P32969,P46778,P62899,P46776,P62857,P63173,P61254,P62906,P62273,P62249,P62753,P30050,P60866,P61927,P62888,P62854,P05386,P62829,P62701,P62280,P26373,P62277,P62263,P61247 50 |
| Base excision repair 0.7116306712339934 3.5169040102052858 0.0004366116453082 0.2345295574711081 0.1336031634643347 19 Q9UGN5,P27695,Q15054,P09429,Q96T60,P39748,P18887,P78549,P29372,P18858,Q9NR33 11 |
| Dna repair pathways full network 0.4741074046236968 3.3520081108998365 0.000802276682932 0.3881024372519212 0.1500166493910874 58 P12004,P35244,P09429,P78549,P40937,Q9Y620,Q96T60,P38398,P29372,P16455,Q9NR33,Q9UGN5,P27695,Q15054,Q9UQ84,P39748,P18887,P32780,Q9BXW9,P15927,P18858 21 |
| Proteasome degradation 0.5122028280309657 3.2112682176539527 0.0013215052795458 0.5548286850424688 0.1549667396194545 42 P49720,P25787,P48556,Q13200,O00233,Q9UNM6,Q9UL46,P20618,P25788,P17980,P16104,O75832,P28072,P28074,P61289,P28066,P62333,P04844,P25789,Q06323 20 |
| Translation factors 0.5039387182562259 2.943927020758516 0.003240764080143 0.8628346790272483 0.1803043288225052 39 P05198,P56537,Q14232,P41567,Q13347,Q13144,P55010,P63241,Q9NR50,O60841,P60842,Q9UI10,P24534,P49770,P26641,O75153,O75822,P62495,P29692,Q15056,Q14240,Q9H074,Q05639,O75821,P06730,P20042,P19525,O00303,O15372 29 |
| Nucleotide metabolism 0.634600437493576 2.654913364128566 0.0079328779486378 0.9923594103876948 0.2603867909625055 16 P19623,P00374,P54098,P11908,P60891 5 |
| Dna mismatch repair 0.5594929937713427 2.607270861309287 0.0091267132636232 0.996343297605724 0.2603867909625055 20 Q15054,Q9UQ84,P35244,P15927,P40937,P18858,Q9NR33 7 |
| Nucleotide excision repair 0.5325436560940333 2.5500149762934115 0.0107718291690579 0.9986773558337256 0.2636943780585385 24 P35251,Q15054,P12004,P35244,P35250,P15927,P32780,P18074,P40937,P18858,Q9NR33,P19447 12 |
| Nucleotide excision repair in xeroderma pigmentosum 0.4783214343130376 2.4473789406217734 0.0143899457243978 0.9998595452058024 0.3195725711248305 33 Q13098,P35251,Q15054,P12004,P35244,P35250,P15927,P18887,P32780,Q92889,P18074,P40937,P38398,P18858,Q9NR33,P19447 16 |
| Methionine de novo and salvage pathway 0.6997654049850084 2.4294515373065795 0.0151216863912093 0.9999108470544826 0.3195725711248305 10 P19623,Q9NZL9,Q96GX9,P52788,Q13126 5 |
| Onecarbon metabolism 0.5804493932036939 2.2119357417100365 0.0269711052186358 0.9999999459306522 0.4126579098451289 15 P00374,P34896,P49914,P35754 4 |
| Folate metabolism 0.5722960641856695 2.1588853947153903 0.0308590592346804 0.9999999953354736 0.4496605774196295 15 P04179,P00374,P34896,P49914 4 |
| Glycerolipids and glycerophospholipids 0.8206896146338604 2.1185755064033183 0.0341263575289452 0.9999999994094826 0.4857053676212668 5 P48651 1 |
| Disorders of folate metabolism and transport 0.6715595384984911 2.062989972995886 0.0391135808519429 0.9999999999751517 0.5128265365167776 8 P00374 1 |
| Male infertility 0.4759929606126462 2.056059530743566 0.0397767784222629 0.9999999999837148 0.5128265365167776 23 P54098,P04179 2 |
| Oxidative stress response 0.6664265611095103 2.036057921607793 0.0417445393898081 0.9999999999953596 0.5128265365167776 8 Q16881,P00390,P04179,P08047 4 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.5452123309789791 1.9807410800071152 0.0476203173487563 0.9999999999998924 0.5128265365167776 15 P41567,P56537 2 |
| Alzheimers disease 0.3159615150481215 1.98016458383739 0.0476850380219131 0.9999999999998967 0.5128265365167776 90 P49720,P25787,O00213,Q9UJX6,P07437,P19784,P30405,O00487,P48556,Q08752,Q13200,O00233,P04350,Q9BUF5,Q9UNM6,P62191,P20618,P42574,P25788,Q9BVA1,Q9Y277,P17980,P67870,P28072,P28074,P28066,P25786,P62333,Q13564,Q99714,O95197,P19525,P25789 33 |
| Alzheimers disease and mirna effects 0.3133252433905765 1.972415249886955 0.0485622223731787 0.9999999999999412 0.5128265365167776 91 P49720,P25787,O00213,Q9UJX6,P07437,P19784,P30405,O00487,P48556,Q08752,Q13200,O00233,P04350,Q9BUF5,Q9UNM6,P62191,P20618,P42574,P25788,Q9BVA1,Q9Y277,P17980,P67870,P28072,P28074,P28066,P25786,P62333,Q13564,Q99714,O95197,P19525,P25789 33 |
| Energy metabolism 0.5559019706821748 1.9542648011157937 0.0506699092725511 0.9999999999999848 0.5128265365167776 14 Q13131,Q06546,Q8WVM0,P54619,Q99873,Q96EB6 6 |
| Cellular proteostasis 0.8285313531291058 1.8869413247521016 0.0591682180283097 1.0 0.5486507489897812 4 Q9NQP4,Q9UHV9 2 |
| Modulators of tcr signaling and t cell activation 0.5426686054844618 1.8689490096700931 0.0616299088231158 1.0 0.5546691794080423 14 Q9UDY8,O95999,Q12824,Q9NQG5,Q15370 5 |
| Autophagy 0.5406496638699068 1.8558803555044097 0.0634706136204288 1.0 0.5549145076528921 14 O95352,Q13131 2 |
| Spinal cord injury 0.4520013796087265 1.8292976766707345 0.0673550265288684 1.0 0.5805813554319368 22 P61586,P27695,P14174,P04083,P06493,P24941 6 |
| Intraflagellar transport proteins binding to dynein 0.6048617945585074 1.8108284563684935 0.0701674099372011 1.0 0.5892629164868666 9 Q9BW83,Q96EX3 2 |
| Neuroinflammation 0.750074884959132 1.8082222899919824 0.0705719107930051 1.0 0.5892629164868666 5 P00403,Q8N9N2 2 |
| Hijack of ubiquitination by sarscov2 0.6346008379983189 1.7678586730439318 0.0770845331994705 1.0 0.5892629164868666 7 Q15369,Q15370,Q13951,Q8TBC4 4 |
| Purine metabolism 0.5961714845363987 1.7624979336202131 0.0779852052039311 1.0 0.5892629164868666 9 P00491,Q9BY32,P60891,P07741,P20839 5 |
| Serine metabolism 0.6234162974214729 1.709510803971267 0.0873563721733328 1.0 0.6022093202776038 7 P00374 1 |
| Nitric oxide metabolism in cystic fibrosis 0.6748306135939304 1.7013251331828332 0.0888819510244971 1.0 0.6022093202776038 6 O94760,Q99873,O95865,Q86X55 4 |
| Endoplasmic reticulum stress response in coronavirus infection 0.6147698971808615 1.6642302580749422 0.0960664234842481 1.0 0.6022093202776038 7 P62140,Q15435,P36873 3 |
| Mevalonate pathway 0.664711917053517 1.652659330896391 0.0984002157316346 1.0 0.6022093202776038 6 P14324,P53602,Q03426 3 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.5307863231167242 1.564443603535063 0.1177134275014872 1.0 0.6490145732514434 11 P35914,P14324,P53602,Q9BWD1,Q03426 5 |
| Common pathways underlying drug addiction 0.527822326915934 1.546567208844437 0.1219676419433783 1.0 0.6664660434763177 11 P62140,P36873,P17612 3 |
| Riboflavin and coq disorders 0.6408951007115173 1.537504923851958 0.1241697102150543 1.0 0.6724943597487896 6 Q5T2R2,Q8NFF5 2 |
| Selenium micronutrient network 0.5241467935306044 1.5243769733145425 0.1274145688618455 1.0 0.6737270515468767 11 Q16881,P04179,P30048,P30044,Q8NFF5 5 |
| Dna replication 0.380939703022208 1.5133114515404027 0.1302005652302931 1.0 0.6737270515468767 33 O43929,O43913,Q15054,P12004,P35244,Q9UBD5,P35250,Q99741,P15927,P49643,P40937,P24941 12 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.6941359157749862 1.318044058455797 0.1874888995071377 1.0 0.8240729173963512 4 P55263 1 |
| Genes related to primary cilium development based on crispr 0.4276866747560042 1.2459241653769697 0.2127922373831101 1.0 0.8432439485167673 16 Q9BW83,Q96EX3,P36405 3 |
| Nicotine effect on dopaminergic neurons 0.5797281241052267 1.2391660027957507 0.2152840280243371 1.0 0.8432439485167673 6 P17612 1 |
| Nad biosynthetic pathways 0.6201180106771362 1.2194610965809731 0.2226692329691668 1.0 0.8432439485167673 5 Q96EB6,Q9UKK3,P43490,Q9UGN5 4 |
| Pyrimidine metabolism 0.315269505576231 1.208741040458942 0.2267623492459085 1.0 0.8432439485167673 45 P33316,Q9H773,Q15054,P04183,O15514,P32321,P15531 7 |
| Dual hijack model of vif in hiv infection 0.6665763791520409 1.2001467740400875 0.2300823425196207 1.0 0.8481272608775802 4 Q15370,Q15369 2 |
| Urea cycle and metabolism of amino groups 0.4823137939621963 1.1903925738686254 0.2338921304606258 1.0 0.8520356181065655 10 Q14353,P52788 2 |
| Purine metabolism and related disorders 0.4278949837568321 1.1837109069707683 0.2365275199454619 1.0 0.8521676372362313 15 P51580,P00491,Q9BY32,P60891,P07741,P20839 6 |
| Homologous recombination 0.4784171770446458 1.1674916718002897 0.2430118696315373 1.0 0.8697266913128704 10 Q15054 1 |
| Kennedy pathway from sphingolipids 0.6538039161794753 1.145606439575546 0.2519580315742593 1.0 0.873785250510717 4 P48651 1 |
| Nephrogenesis 0.8093767546322319 1.1437859912725177 0.2527124008830015 1.0 0.873785250510717 2 O95747 1 |
| Parkinubiquitin proteasomal system pathway 0.3348413824813387 1.137762178528337 0.2552198018657963 1.0 0.8758583798873415 37 P62333,Q0VDF9,O00233,Q9UNE7,P04350,Q9BUF5,Q9UNM6,P17980,P62191,P07437,O75832,O00487,P48556,Q13200 14 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.4510590377484658 1.135479981789456 0.2561742647056113 1.0 0.8758583798873415 12 P08047,O94992 2 |
| Head and neck squamous cell carcinoma 0.367700430597853 1.1301867621616746 0.2583975366058268 1.0 0.8785516244598114 22 P42771,Q13131,Q04721,P11802,P62753 5 |
| Estrogen signaling pathway 0.4776897400454424 1.0913735618923266 0.2751085408481173 1.0 0.8852250236210139 9 P08047,P17612 2 |
| Hereditary leiomyomatosis and renal cell carcinoma pathway 0.4339934203643762 1.0871962749427646 0.2769500767393307 1.0 0.8852250236210139 13 P62753,P54619,Q13131 3 |
| Onecarbon metabolism and related pathways 0.4337608132987544 1.0857062008459568 0.2776089964190342 1.0 0.8852250236210139 13 P04179 1 |
| Canonical and noncanonical tgfb signaling 0.7944974733295935 1.0840091922607389 0.2783607231603298 1.0 0.8852250236210139 2 Q16539 1 |
| Biomarkers for pyrimidine metabolism disorders 0.5052200518081049 1.082877300248639 0.2788628887279292 1.0 0.8852250236210139 7 P31350,Q9H0P0,P12277 3 |
| Leptin signaling pathway 0.3374555459700641 1.0627355793750788 0.2879018810435423 1.0 0.8852250236210139 31 P08047,P61586,Q07666,Q13131,O00629,P62753,Q16539,P49840 8 |
| Oxidative damage response 0.4695020689106758 1.0449347385460488 0.2960531329995688 1.0 0.8852250236210139 9 P42574,O95429,P12004,O95551,Q16611 5 |
| 3q29 copy number variation syndrome 0.4070545680394444 1.0412676341853355 0.2977513536085814 1.0 0.8852250236210139 15 P35240,Q96EX3,P63167 3 |
| Transsulfuration pathway 0.4961223519480175 1.0346596980004046 0.3008278637419119 1.0 0.8852250236210139 7 P25325,P17174,P26358,Q9NZL9 4 |
| Hippo signaling regulation pathways 0.3581310415390429 1.0233288516525187 0.3061523867157532 1.0 0.8852250236210139 20 P35240,P61586,P17612,Q13131 4 |
| Biomarkers for urea cycle disorders 0.778775968557 1.0212690284524488 0.3071269958735212 1.0 0.8852250236210139 2 Q14353 1 |
| Leukocyteintrinsic hippo pathway functions 0.5326194808834523 1.0095762183763757 0.312698368200303 1.0 0.8852250236210139 6 Q92597,P61586,Q16539 3 |
| Apoptosis modulation and signaling 0.3548766151577509 1.0095550148435488 0.3127085313163311 1.0 0.8852250236210139 21 P42575,P42771,Q16611 3 |
| Burn wound healing 0.4497525217771405 0.9997298010968092 0.3174412859773174 1.0 0.8852250236210139 10 P07737,P31949,Q99439 3 |
| Nrf2 pathway 0.3513852770686457 0.9955877874371132 0.3194504709828085 1.0 0.8852250236210139 22 Q16881,P28161,Q14914,P21266,P00390 5 |
| Transsulfuration and onecarbon metabolism 0.363937713686235 0.9895626458261936 0.3223879355807346 1.0 0.8852250236210139 19 P00374 1 |
| Nanomaterial induced apoptosis 0.4871771914487166 0.9874143416181468 0.3234395564746 1.0 0.8852250236210139 7 Q16611,P55212,O95831 3 |
| 1q211 copy number variation syndrome 0.4351347276423323 0.9849591421094728 0.3246441407644655 1.0 0.8852250236210139 11 Q16625,P54619,Q13131 3 |
| Ethanol effects on histone modifications 0.4345431949193026 0.9814097653198768 0.326390712451766 1.0 0.8852250236210139 11 P00374 1 |
| Glycogen synthesis and degradation 0.3900382853994105 0.9810600601950542 0.3265631246254981 1.0 0.8852250236210139 16 P11216,Q13362,Q15257,P49840,P46976 5 |
| Lipid metabolism pathway 0.4170695305750228 0.9792195411916396 0.3274715152645064 1.0 0.8852250236210139 13 P54619,P17612,Q13131 3 |
| Mitochondrial complex i assembly model oxphos system 0.343073681608711 0.9617680171904792 0.3361661470744836 1.0 0.8852250236210139 24 O75380,O96000,Q8IUX1,Q9P032,Q96CU9,Q9Y6M9,P19404,O75489,P51970,P03915,Q9BU61 11 |
| Breast cancer pathway 0.3272508345266882 0.9532808571280628 0.3404477879337118 1.0 0.8852250236210139 29 P08047,P67870,P63208,P19784,P38398,Q16611 6 |
| Apoptosis 0.3591100878600808 0.952522539466471 0.3408320405527281 1.0 0.8852250236210139 19 P42771,Q16611 2 |
| Follicle stimulating hormone fsh signaling pathway 0.4415478507116722 0.9520947641399756 0.3410489241696581 1.0 0.8852250236210139 10 P62753,P17612 2 |
| Angiotensin ii receptor type 1 pathway 0.5197239389152168 0.9473134412357238 0.3434790836355907 1.0 0.8852250236210139 6 P08047,Q13485 2 |
| Malignant pleural mesothelioma 0.2638029255998545 0.9025126062263734 0.3667846279098876 1.0 0.8885655903687204 80 Q15118,P08047,P42771,Q13363,O95816,Q13131,P09429,P11802,P62753,Q06546,P54619,P67870,P19784,P35240,P38398,P24941,Q16611 17 |
| Pathogenic escherichia coli infection 0.3248165072655427 0.9004246437176884 0.3678943110183206 1.0 0.8885655903687204 28 P61586,O00401,Q16625,P04350,Q9BUF5,O43639,P07437,O15145 8 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.5485424074018516 0.895498906415265 0.3705204501223882 1.0 0.8885655903687204 5 P49840,Q16611 2 |
| Hippoyap signaling pathway 0.5929609589482515 0.8886966060742872 0.3741661555905193 1.0 0.8885655903687204 4 P35240 1 |
| Vitamin d in inflammatory diseases 0.4550030019962071 0.8879058897001756 0.3745913763319115 1.0 0.8885655903687204 8 O60244,Q13485,Q16539 3 |
| Airway smooth muscle cell contraction 0.5413925833296246 0.863732257242109 0.3877349891315669 1.0 0.90798139649693 5 P62140 1 |
| Aspirin and mirnas 0.7400557880581463 0.8619573464510367 0.3887109900035876 1.0 0.90798139649693 3 P53602 1 |
| G1 to s cell cycle control 0.3128999845806379 0.827518792072153 0.4079430753006501 1.0 0.908261383540775 30 O43929,P42771,P35244,Q9UBD5,P11802,P06493,P24941 7 |
| Methylation pathways 0.578088677911015 0.8271995128954727 0.4081239877021456 1.0 0.908261383540775 4 P51580,Q9NZL9 2 |
| Fluoropyrimidine activity 0.4077433741441951 0.8223087224751117 0.4109012136857677 1.0 0.9111287781727893 11 P00374,Q92820,P04183,P18074 4 |
| Atm signaling pathway 0.3480698736095254 0.8030902645971285 0.4219225642714765 1.0 0.9178984879380576 18 P30307,O96017,P42575,P38398,P24941 5 |
| Regucalcin in proximal tubule epithelial kidney cells 0.4387988198529226 0.801308234644081 0.4229532248342029 1.0 0.9178984879380576 8 P42574,Q13485,Q16611 3 |
| Ciliopathies 0.3259401803654091 0.77914719872249 0.4358930095089728 1.0 0.930803765731072 21 Q9BW83,Q96EX3,Q15051 3 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.3356870281661528 0.7758245854951084 0.437852565474162 1.0 0.930803765731072 19 Q13131 1 |
| Interactions between loxl4 and oxidative stress pathway 0.5576362973035658 0.7439579047762682 0.4569019422856337 1.0 0.9478383171134112 4 Q96EB6 1 |
| Apoptosis modulation by hsp70 0.4127132533822525 0.7294707162185297 0.4657137743591115 1.0 0.956432315126766 9 P42574,O95831,P55212,P42575 4 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.4357160357568486 0.7213567155684032 0.4706900704775378 1.0 0.9622938729159576 7 Q13131 1 |
| Biotin metabolism including iems 0.4225602595400329 0.7160752224283367 0.4739449023193938 1.0 0.9622938729159576 8 Q96RQ3,P50747 2 |
| Retinoblastoma gene in cancer 0.264391123399817 0.7048266067981329 0.4809181484914586 1.0 0.9622938729159576 54 P12004,P35244,P09429,P00374,P11802,O75446,P40937,P20248,P26583,P31350,P14635,P04818,Q9UNN5,Q15054,Q16204,Q00534,O95067,P26358,P06400,P15927,P06493,Q13309,P24941 23 |
| Cholesterol biosynthesis pathway 0.3792732967983241 0.698335355196045 0.4849674936645254 1.0 0.9622938729159576 12 P14324,P53602,Q03426 3 |
| Netrinunc5b signaling pathway 0.3553405716910708 0.6981384078409135 0.4850906405378843 1.0 0.9622938729159576 15 P42574,P61586,P62136,Q15257,Q16539 5 |
| Ketone bodies synthesis and degradation 0.5430996628539281 0.685948989228517 0.4927452761724686 1.0 0.9622938729159576 4 P55809 1 |
| Dna damage response only atm dependent 0.3073255525197408 0.6848312659346893 0.4934504031723707 1.0 0.9622938729159576 25 Q15118,P04179,Q13362,P61586,P42771,P09429,Q16822,Q16611 8 |
| Mitochondrial gene expression 0.4164291227281989 0.6843947325006017 0.4937259413326971 1.0 0.9622938729159576 8 P08047,Q06546 2 |
| Hypertrophy model 0.6826734063465296 0.659427934737111 0.5096210087074817 1.0 0.9716138857600586 3 O75083,P20248 2 |
| Cannabinoid receptor signaling 0.4221365804895408 0.6537432642118415 0.5132772246864485 1.0 0.9748010983255512 7 P17612,Q16539 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2866621520197285 0.6328844762758387 0.5268090859262045 1.0 0.9799609744280764 35 P08047,Q13131,P54619,P14324,P53602,P17612,Q9NR31,Q96EB6 8 |
| T cell receptor and costimulatory signaling 0.4150264930364469 0.6189602929568983 0.5359425172507577 1.0 0.9862244636405753 7 Q15118,P49840 2 |
| Cell cycle 0.255808904820914 0.6183159244274664 0.5363671067826903 1.0 0.9862244636405753 60 P12004,Q9UBD5,P11802,Q9UJX4,P30307,Q14674,Q13042,O43684,P62258,P31946,O96017,P63208,Q99741,P42771,O95067,Q13485,O43929,P61981,P06493,Q13309,P24941 21 |
| Insulin signaling 0.2567439630851798 0.6179290106831515 0.53662213462796 1.0 0.9862244636405753 51 P46976,Q96PE3,Q13131 3 |
| Melanoma 0.3286084707697556 0.6147739966385852 0.538703984270196 1.0 0.9866731033008228 17 P42771 1 |
| Fibrin complement receptor 3 signaling pathway 0.4811138441925015 0.6051556606826635 0.5450755736771407 1.0 0.9921143418748988 5 P61586 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3680905441084386 0.5968986682269218 0.5505750364968831 1.0 0.9958927393305594 11 Q15118,P49770 2 |
| Thermogenesis 0.284693440940743 0.5898344203305075 0.5553016639105053 1.0 0.9963967058941816 32 O43772,Q13131 2 |
| Vasopressinregulated water reabsorption 0.3157385529206854 0.5778651312917483 0.5633551782095103 1.0 0.9999131276478104 18 Q96FJ2,Q13561,Q8NCM8,P17612,Q9Y6G9,P63167,Q9UJW0,P51148 8 |
| Leptin and adiponectin 0.6581856348983051 0.5775438985492516 0.5635720927180656 1.0 0.9999131276478104 3 Q13131 1 |
| Dna irdamage and cellular response via atr 0.264696757530179 0.5769938519037511 0.5639436087606255 1.0 0.9999131276478104 43 P08047,O43324,Q9UQ84,P39748,P30307,O96017,P38398,P24941 8 |
| Peroxiredoxin 2 induced ovarian failure 0.6573996068520016 0.5749718089781035 0.5653103630165726 1.0 0.9999131276478104 3 P42574,Q9UGN5 2 |
| Striated muscle contraction pathway 0.4376859020375914 0.5679488634168289 0.5700696912513343 1.0 1.0 6 P67936 1 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3612964068561656 0.5600810567729764 0.5754241508107825 1.0 1.0 11 P67870,Q13363 2 |
| Nocgmppkg mediated neuroprotection 0.4304008559303193 0.5365503384162568 0.5915782557400129 1.0 1.0 6 Q13555,Q13557 2 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.3362214536227246 0.5330747171506868 0.5939818598239031 1.0 1.0 14 Q96EB6,Q13131 2 |
| Constitutive androstane receptor pathway 0.4157908100731301 0.4752510596895561 0.6346080374563337 1.0 1.0 6 P08047,Q15257 2 |
| Metapathway biotransformation phase i and ii 0.2836353242484254 0.4681612762910918 0.6396692619778563 1.0 1.0 21 P28161,Q9GZZ1,P78417,O43488,P00390,P21266,P14550,Q86UY6,O43708 9 |
| Nuclear receptors metapathway 0.2420783457880935 0.4627662680054312 0.6435319123403742 1.0 1.0 52 Q16881,P28161,P08047,Q14914,Q99615,P11802,Q15257,P21266,P06493,Q15185 10 |
| Small cell lung cancer 0.3039529961876417 0.4592855406435285 0.646029129789351 1.0 1.0 17 Q16611,P63208 2 |
| Nad metabolism 0.6197697276046041 0.4566242084541273 0.6479411758431999 1.0 1.0 3 Q96EB6,P43490 2 |
| Wnt signaling 0.2934590540061077 0.4353587481749267 0.6633020483034169 1.0 1.0 18 P67870,Q13363,P19784 3 |
| Vitamin b12 disorders 0.4355401424280825 0.4272824993066562 0.6691735780891537 1.0 1.0 5 Q9Y4U1 1 |
| G13 signaling pathway 0.2902772031318675 0.4161390344087292 0.6773082680346949 1.0 1.0 18 P62140,P07737,P61586,P23528 4 |
| Photodynamic therapyinduced ap1 survival signaling 0.3215459732635277 0.415838656005367 0.6775280702913884 1.0 1.0 13 P42771 1 |
| Serotonin htr1 group and fos pathway 0.3376477208778979 0.3949955899115587 0.6928461426454289 1.0 1.0 10 P09471,P61586,P04899,P63096,Q16539,P52564,P08754,P27361,P28482 9 |
| Tcell activation sarscov2 0.2966661754206454 0.3832295978455227 0.7015495342493918 1.0 1.0 16 P42771,Q9UDY8 2 |
| Nonhomologous end joining 0.4590447389000063 0.3797713888897425 0.7041151223223825 1.0 1.0 4 P12956 1 |
| Signal transduction through il1r 0.3421412098299515 0.3773960877721238 0.7058792738224959 1.0 1.0 9 P52564,Q15750,Q16539 3 |
| Bmp signaling in eyelid development 0.5979786636721072 0.3760604110813871 0.7068719850598 1.0 1.0 2 Q13485 1 |
| Nonalcoholic fatty liver disease 0.2323688221675555 0.3708459272110012 0.7107522915816504 1.0 1.0 51 O75380,Q13131,P00403,P54619,P51970,P49840,O75489,Q16611 8 |
| Pilocytic astrocytoma 0.5892070180956164 0.3685438304291421 0.7124677694065784 1.0 1.0 3 Q06124 1 |
| 16p112 distal deletion syndrome 0.3398164996033072 0.3671156752027031 0.7135327352964285 1.0 1.0 9 Q99873,Q9UJ41 2 |
| Integrated cancer pathway 0.2662854911860807 0.3558977445386082 0.7219171449593234 1.0 1.0 21 P38398,P24941,O96017,P06493 4 |
| Interleukin1 induced activation of nfkb 0.5808833300454411 0.3460009458212023 0.7293420039282992 1.0 1.0 3 Q13404 1 |
| Myd88 distinct inputoutput pathway 0.5808833300454411 0.3460009458212023 0.7293420039282992 1.0 1.0 3 Q13404 1 |
| Thyroid stimulating hormone tsh signaling pathway 0.2602047515455087 0.3328909669409338 0.7392165882842794 1.0 1.0 24 P27695,P11802,P62753,Q16539,P24941,Q15418 6 |
| Physicochemical features and toxicityassociated pathways 0.2693494639321951 0.3320377805970855 0.7398607310072887 1.0 1.0 19 P07737,P07197,P35080 3 |
| Molybdenum cofactor moco biosynthesis 0.5735628694306927 0.3267273179192738 0.7438741365068737 1.0 1.0 3 O96007 1 |
| Parkinsons disease pathway 0.3206066297402025 0.3189381151493718 0.7497734407311014 1.0 1.0 10 Q99497,P42575,P55212,Q16539 4 |
| Endochondral ossification with skeletal dysplasias 0.3470490084466568 0.318059272141091 0.7504399767557253 1.0 1.0 7 Q96QD8 1 |
| Endochondral ossification 0.3470490084466568 0.318059272141091 0.7504399767557253 1.0 1.0 7 Q96QD8 1 |
| Resistin as a regulator of inflammation 0.3455158841720587 0.3121353551073504 0.7549376583511846 1.0 1.0 7 P19174,P31751,O15111,P19838,Q16539,P27361 6 |
| Dopamine metabolism 0.5668850883379948 0.3096117997168081 0.7568561820694126 1.0 1.0 3 P17612 1 |
| Myometrial relaxation and contraction pathways 0.2471287591184695 0.2994858000698589 0.7645694050343583 1.0 1.0 30 P19174,P10644,P31946,Q99439,P08047,Q9Y3B8,P78417,Q06546,P61981,Q04917,Q13555,P62879,P17612,P62258,P49407,Q13557 16 |
| Neuroinflammation and glutamatergic signaling 0.2469871363594015 0.2985603161535252 0.7652755481806484 1.0 1.0 30 P62140,P78330,P62136,Q13485,P36873,P17174,P17612,P23528,P34896,Q96QD8 10 |
| Amyotrophic lateral sclerosis als 0.3042714793452841 0.2844182417544504 0.7760898810986152 1.0 1.0 11 P52564,P07197,O96008,Q16539 4 |
| Camkk2 pathway 0.2934957161162339 0.2817450359924027 0.7781390190198352 1.0 1.0 13 Q9Y2X7 1 |
| Monoamine transport 0.3878795179748138 0.2675428404694533 0.7890512339499995 1.0 1.0 5 P30307 1 |
| Exerciseinduced circadian regulation 0.2785028724300625 0.2671447182923335 0.7893577380796626 1.0 1.0 15 P21266,Q13185 2 |
| Angiogenesis 0.4212118071417425 0.2658889463561021 0.7903247383030525 1.0 1.0 4 Q16539 1 |
| Bladder cancer 0.3072536000616978 0.2641040401043105 0.791699750837539 1.0 1.0 10 P42771 1 |
| Kallmann syndrome 0.4169872630691829 0.2543725669276432 0.7992077424981867 1.0 1.0 4 Q9P2D1,Q06124 2 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.2176781469382776 0.2514230007150001 0.8014870867129464 1.0 1.0 49 O43639,P10586,P67809,Q13131 4 |
| Nonsmall cell lung cancer 0.243653408011653 0.2303273705770572 0.8178373936429488 1.0 1.0 22 P42771 1 |
| Mirnas involvement in the immune response in sepsis 0.3473109046950025 0.2276205396243181 0.81994125076017 1.0 1.0 6 Q15750,Q16539 2 |
| Dna damage response 0.2309159920723696 0.2013989536572749 0.8403866333102317 1.0 1.0 31 P42574,P35251,Q9Y3B8,P11802,P06400,P30307,P15927,P16104,O96017,Q9BXW9,P06493,O95067,P14635,P38398,P24941 15 |
| Complement system 0.2887470748616871 0.1959236142505731 0.8446699539556826 1.0 1.0 10 P26885 1 |
| Mirna regulation of dna damage response 0.228435690774511 0.1882578969969859 0.8506744885118176 1.0 1.0 32 P42574,P35251,Q9Y3B8,P11802,P06400,P30307,P15927,P16104,O96017,Q9BXW9,P06493,O95067,P14635,P38398,P24941 15 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.2698484159847278 0.1711180319391819 0.8641309575516156 1.0 1.0 12 P49840,P24941 2 |
| Unfolded protein response 0.3496646688094802 0.1653546628930705 0.868664836149436 1.0 1.0 5 P42575 1 |
| Disruption of postsynaptic signaling by cnv 0.2935336678955847 0.1630216022173461 0.8705014260836752 1.0 1.0 8 P61981,Q13557,Q12959,P27361,Q13555 5 |
| Tyrobp causal network in microglia 0.3449582118531437 0.1545785234574256 0.8771536022628368 1.0 1.0 5 P61916,Q15418 2 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.340807403738723 0.145416176094085 0.8843822937352823 1.0 1.0 5 Q16539 1 |
| Gastrin signaling pathway 0.2187963003107176 0.1404349553751566 0.8883163411058943 1.0 1.0 33 P08047,P62753,P42771,P17612 4 |
| Heme biosynthesis 0.3352065186850268 0.1335631842685855 0.8937479979768268 1.0 1.0 5 P22830,P36551,P06132,P08397 4 |
| Pancreatic adenocarcinoma pathway 0.2171154047636413 0.1197241139415582 0.9047016975906448 1.0 1.0 26 P61586,P42771,Q16611 3 |
| Fluoroacetic acid toxicity 0.3183478505198103 0.1014336498135436 0.9192062255282558 1.0 1.0 5 P51648,P05091,Q99798,P49189 4 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.3452247191011197 0.1009781912966564 0.9195677724970176 1.0 1.0 4 O15111,P19838,P52564 3 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.3448345309714038 0.1003703703388275 0.9200502919987464 1.0 1.0 4 P17612 1 |
| Hepatitis c and hepatocellular carcinoma 0.2248857404284668 0.0794266107489325 0.9366933031823328 1.0 1.0 15 P31350,P38398,Q13485,Q16539 4 |
| Pi3kakt signaling pathway 0.1885493489223508 0.0739365097020292 0.94106090479765 1.0 1.0 46 P38398,P24941,Q16822,Q13131 4 |
| Glutathione metabolism 0.2565393042222306 0.0613760452522198 0.951059729504906 1.0 1.0 7 P28161 1 |
| Hedgehog signaling pathway wp4249 0.2721492123120524 0.0590008828866273 0.9529514048968212 1.0 1.0 6 P17612 1 |
| Ciliary landscape 0.1937652707580077 0.057920911223048 0.9538116263355774 1.0 1.0 111 Q9Y312,Q96FJ2,A0AVF1,Q9UBW8,Q9UNS2,P08579,P10619,P48556,P60660,Q12904,Q9BT78,Q8IYI6,O60841,Q9UNM6,Q92905,Q96EX3,P61006,Q9Y266,Q9H7D7,Q9NV70,Q9BW83,P07197,Q8IUR7,O60942,Q7L5N1,Q15555,P62333,P61962,Q8IVV7,Q15051,P63167,Q8TAG9 32 |
| Measles virus infection 0.1960187439423306 0.0510463569528688 0.9592885811674132 1.0 1.0 27 P67870,P24941,Q16611,P19784 4 |
| Il3 signaling pathway 0.2154929577464842 0.0505757687625421 0.9596635718342208 1.0 1.0 14 P27348,P17252,P31946,P62993,P22681,P07948,P17612,P27361,P46109,Q02750,Q06124,P28482,P12931 13 |
| Bdnftrkb signaling 0.2345991561181462 0.0445039514858932 0.9645027022693118 1.0 1.0 9 P19174,P01111,P62993,Q15334,P42345,Q02750,Q15418,P28482 8 |
| Translation inhibitors in chronically activated pdgfra cells 0.1936790353762544 0.0442080265553274 0.9647385840442932 1.0 1.0 22 Q15118,Q14240,P62753,Q16539,P52564,P17612,P60842,Q15418 8 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.2726366494220492 0.0401539701650634 0.9679703744963302 1.0 1.0 5 Q16539 1 |
| Congenital generalized lipodystrophy cgl 0.3882650196518927 0.0350821914949522 0.9720142017990114 1.0 1.0 2 P62993 1 |
| Il1 signaling pathway 0.1948197771787893 0.0300422417533004 0.9760333643137584 1.0 1.0 17 Q13404,Q15750,P52564,Q16539,P51617 5 |
| Cell migration and invasion through p75ntr 0.2272646558194528 0.0213489069103794 0.9829673306425096 1.0 1.0 7 P61586 1 |
| Tgfbeta signaling pathway 0.1776740036844232 0.0207987576875842 0.9834061887473138 1.0 1.0 42 Q15118,P08047,P61586,Q9Y5K5,Q15750,Q16539,Q92905,Q9Y3F4,P06493,P63208,Q13485 11 |
| Ltf danger signal response pathway 0.3451277730974482 0.0207886675069788 0.9834142378063264 1.0 1.0 3 P51617,P19838 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.2366498032602644 0.0195452570827164 0.9844061339969434 1.0 1.0 6 P07099,Q16539,P09601,P48507,Q14145 5 |
| Nipbl role in dna damage cornelia de lange syndrome 0.2279916670316939 0.0131684163324231 0.989493427571544 1.0 1.0 6 Q13185 1 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.2150688782682025 0.0100504535552866 0.9919810332808632 1.0 1.0 7 P19174,O95782,P61586,O94973,P63010,Q13464 6 |
| Il5 signaling pathway 0.1799816059617438 0.0017134855396064 0.998632837011795 1.0 1.0 12 P62753,Q15418,P49840 3 |
|
|
